LONZA Trademark

Trademark Overview


On Thursday, October 12, 2023, a trademark application was filed for LONZA with the United States Patent and Trademark Office. The USPTO has given the LONZA trademark a serial number of 79389966. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 14, 2024. This trademark is owned by Lonza Ltd.. The LONZA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use; biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel, powder, and liquid or as food additives

Biological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, a...

General Information


Serial Number79389966
Word MarkLONZA
Filing DateThursday, October 12, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesBiological materials for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for medical, clinical and commercial use; human or animal blood, tissue, blood cells and stem-cells for medical, clinical and commercial use; biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use; bioscience products, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical, clinical and commercial use in human and animal therapies; dietary and nutritional supplements; nutritional ingredients in the nature of nutritional supplements as components of dietary regimes and nutritional supplements for medical use in bulk, in the form of tablets, capsules, gel, powder, and liquid or as food additives
Goods and ServicesBiological materials, namely, genetically modified cells for scientific and research use; biological tissue in the nature of genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal and synthetic proteins for scientific and pharmaceutical research; biological tissue, namely, human or animal blood, tissue and stem cells for use in scientific and pharmaceutical research; bioconjugates for scientific and pharmaceutical research; bioscience products, being biological tissue in the nature of primary cells, cell cultures and transfection compounds for life-science research; nutritional chemical compounds in bulk powder, tablet, capsule, gel, powder, and liquid form used in the manufacture of dietary and nutritional supplements or food additives; biological preparations, namely, genetically modified cells, genetic material and vectors in the nature of cosmids, plasmids, viral material, or chromosomes for the production of human, animal and synthetic proteins for commercial use, other than for medical or veterinary use; biological preparations for use in industry and science, namely, blood, tissue, blood cells and human or animal stem cells, for commercial use; biological preparations for use in industry and science, namely, bioconjugates for drug development; biological preparations for use in industry and science, namely, primary cells, cell cultures and transfection animal tissue for commercial use in human and animal therapies; biopharmaceutical chemicals, namely, monoclonal antibodies and proteins for scientific and pharmaceutical research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLonza Ltd.
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, February 22, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 23, 2024ASSIGNED TO EXAMINER
Tuesday, February 27, 2024APPLICATION FILING RECEIPT MAILED
Monday, March 18, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 19, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, April 6, 2024REFUSAL PROCESSED BY MPU
Saturday, April 6, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2024REFUSAL PROCESSED BY IB
Monday, June 17, 2024ASSIGNED TO LIE
Friday, August 16, 2024NON-FINAL ACTION E-MAILED
Friday, August 16, 2024NON-FINAL ACTION WRITTEN
Friday, August 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER